Archive for the ‘Freeman in the News’ Category
Tuesday, March 25th, 2014
From New Orleans CityBusiness, March 25, 2014:
The report, authored by Tulane Energy Institute president Eric Smith and sponsored by Chevron, posits that relying on one technology, industry or energy feedstock such as natural gas is economically risky. Therefore the creation of “downstream value added opportunities” will be the key to extending the energy and manufacturing boom beyond the immediate commodity conversion stage.
To read the article in its entirety, visit NewOrleansCityBusiness.com.
Wednesday, March 5th, 2014
Ira Solomon, dean and Debra and Rick Rees Professor of Business, recently co-authored an opinion piece for CFO.com criticizing the Public Company Accounting Oversight Board (PCAOB) for misleading statements regarding the quality of public company audits.
Solomon and co-author Mark Peecher, professor of accountancy at the College of Business at the University of Illinois at Urbana-Champaign, take issue with the PCAOB for its use of the term “audit failure” — which has traditionally referred to the joint occurrence of an unqualified audit opinion and materially misleading financial statements — to describe audits in which the auditor simply failed to obtain sufficient appropriate evidence to support its opinion on the financial statements, regardless of the fairness of the financial statements in question. The authors go on to say that PCAOB criticisms of auditors’ evidential bases are themselves open to criticism.
One reason is that PCAOB inspections usually occur after fieldwork, so hindsight bias can surface, especially when inspectors try to assess audit work on management’s estimates, which often are predicated on future economic events. That is, inspectors form retrospective judgments about auditors’ judgments regarding the reasonableness of management’s judgments. The management judgments in question concern things like the reasonableness of complex financial-statement estimates or the sufficiency of internal controls. It is hard to manufacture precision at the end of this judgment chain when it starts with so much ambiguity and uncertainty.
To read the article in its entirety, visit CFO.com:
Thursday, January 16th, 2014
From The Times-Picayune | NOLA.com, Jan. 15, 2014:
Geoffrey Smith, visiting assistant professor of finance at Tulane University, described Bitcoin as an “alternate means of storing value” that investors are using as a hedge against the dollar. He said it needs more stability, but he thinks it has potential to catch on, particularly because of its inflation-fighting finite supply.
The system is expected to create 21 million Bitcoins and then stop issuing more. The coins often are traded as fractional units. The web sites bitcoinexchangerate.org and bitcoincharts.com reported Wednesday morning that one Bitcoin translated to about $830.
“People can use anything as currency,” Smith said. “In jail, people use cigarettes.”
“There’s nothing special about paper with green ink,” and nothing wrong with competing currencies, he argued. “It’s based on faith that it has value.”
To read the article in its entirety, visit NOLA.com.
Tuesday, November 26th, 2013
From WSJ.com, Nov. 25, 2013:
And while such superstitions can be broken, says Dr. Johar, it often takes a lot of negative evidence before people are willing to part with their lucky rituals. That’s because they “provide some sort of a hedge against uncertainty,” says Eric Hamerman, an assistant professor of marketing at Tulane University’s Freeman School of Business who, with Dr. Johar, co-wrote the study, published in October in the Journal of Consumer Research.
To read the article in its entirety, visit WSJ.com.
Monday, November 11th, 2013
From HBR.org, Nov. 8, 2013:
Ralph Maurer, professor of practice and interim executive director of the Levy-Rosenblum Institute for Entrepreneurship, co-authored an article for the HBR Blog Network about how Tulane School of Medicine is embracing disruptive innovation to deal with some of the challenges currently facing academic medicine. The article was written in collaboration with Benjamin P. Sachs, senior vice president and dean emeritus of Tulane School of Medicine, Marc J. Kahn, senior associate dean of Tulane School of Medicine, and Steven A. Wartman, president and CEO of the Association of Academic Health Centers.
One solution to this problem is moving the majority of primary and secondary healthcare delivery into the community. After Hurricane Katrina, Tulane partnered with a network of Federally Qualified Health Centers in order to provide services to low and middle-income patients in community-based clinics designated as medical homes. These not only provide less expensive care, but also provide the kind of experiential learning necessary to teach expertise to trainees.
To read the article in its entirety, visit HBR.org.
Thursday, October 10th, 2013
From MarketWatch, Oct. 10, 2013
In the wake of Twitter’s recent IPO filing, Professor of Management Science Geoffrey Parker co-authored a commentary for MarketWatch on the growing impact of platform firms, companies with networked ecosystems that connect multiple players and provide tools for those participants to contribute and interact.
Ultimately, this transformation redefines competition. Firms that once sought advantage based on the strength of their internal resources and channel access now face competitors that harness armies of connected users and ecosystems of resources. Apple’s App Store, hosting nearly a million applications, offers a compelling testimony to the power of ecosystems.
To read the article in its entirety, visit MarketWatch:
Wednesday, September 11th, 2013
From Bankrate, Sept. 11, 2013
Bankrate’s Jay MacDonald spoke to Assistant Professor of Marketing Janet Schwartz, an expert on the consumer experience of health care, for her reaction to a new survey on Obamacare.
Schwartz believes some of the bewilderment with the health care law stems from America’s employer-based health care system, which allows most people to avoid understanding the basics of health insurance.
“Purchasing health care turns out to be one of our biggest expenses, and yet it is very intangible,” Schwartz says. “If you purchase homeowners or car or life insurance, you know exactly what you’re getting, but with health insurance, it’s not clear. For most people, their employer plan has provided this huge buffer.”
To read the article in its entirety, visit Bankrate.com.
Monday, June 24th, 2013
From Financial Times, June 23, 2013:
The 2013 FT Masters in Finance ranking of the top 40 full-time pre-experience programmes has a very western feel: it includes one business school from Australia, one from China, five from the US and 33 from Europe. The distribution of the 2013 enrolled cohorts could hardly be more different, however.
Half of the students on these programmes are from Asia, with two-thirds of those coming from China. “China’s pent-up demand for Masters in Finance is supplying a large number of applicants to western schools,” says Clifton Brown from Freeman Business School at Tulane University.
To read the article in its entirety, visit FT.com.
Tuesday, June 18th, 2013
From Scientific American, June 17, 2013:
Janet Schwartz, assistant professor of marketing at the Freeman School and an expert on the intersection of marketing and public policy with regard to health care, co-authored a guest blog for Scientific American on the problem of current health insurance models.
Rather than tolerate increases in co-pay and deductible, shouldn’t we be able to pay less because we do not value particular options? Better yet, shouldn’t the options relate to the likelihood of benefit? Those of us who consider interventions with unlikely or small benefits of little value should not be asked to burden the cost of providing such for those who value such. We should be offered a “high efficacy option” at lower cost than an “any efficacy option” and no one should be offered an option that indemnifies for interventions that have been studied and cannot be shown to offer a clinically meaningful benefit.
To read the article in its entirety, visit scientificamerican.com.
Thursday, February 7th, 2013
From Fox Business, Feb. 7, 2013
What’s in a price? When it comes to medicines, the cost could affect your health and well-being, according to Janet Schwartz, assistant professor of marketing at the A. B. Freeman School of Business at Tulane University in New Orleans. A recent study found in the Journal of Consumer Research, “Goods: Changing the price of medicine influences perceived health risk,” by Schwartz and Adriana Samper of the W.P. Carey School of Business at Arizona State University, found that the cost of a medication directly impacts how consumers view their risk of catching an illness associated with the medicine.
To read the entire article, visit FoxBusiness.com.